Department of Neurology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), German; Department of Radiology, Bundeswehrkrankenhaus Berlin, Scharnhorststr. 13, 10115 Berlin, Germany.
Department of Psychiatry and Psychotherapy, University Hospital Leipzig, Semmelweisstr. 10, 04103 Leipzig, Germany; Department of Biology, University of Leipzig, 04103 Leipzig, Germany.
Neuroimage Clin. 2024;44:103687. doi: 10.1016/j.nicl.2024.103687. Epub 2024 Oct 11.
Alzheimer's disease (AD) is characterized by progressive cognitive decline and specific brain atrophy patterns, primarily involving the medial temporal lobes. A number of studies have discussed hypothalamic involvement in AD with consecutive metabolic and/or autonomic disturbances yet only few studies have investigated hypothalamic atrophy in AD and its early stages in particular.
We applied semi-automated volumetry of the hypothalamus (HTH) in 3 T MRI in a sample N = 175 participants [age 74.9 ± 7.22; gender 85 m/90f; cognitively normal controls (CN; N = 56); amnestic mild cognitive impairment (MCI; N = 78); AD (N = 41)] from the Alzheimer's Disease Neuroimaging Initiative (ADNI). In addition, we used voxel-based morphometry (VBM), cortical thickness (CTH) analyses and source-based morphometry (SBM) derived networks of structural covariance to investigate brain structural covariance patterns of the HTH under consideration of diagnostic groups, β-amyloid (AB) positivity and apolipoprotein E (APOE) ε4 status.
Hypothalamic atrophy was observed in both early and advanced disease stages (i.e. hypothalamic volume CN > MCI > AD). VBM, CTH analysis and SBM revealed positive associations between hypothalamic volume (HV) and AD-vulnerable regions, largely corresponding to the Papez circuit and brain regions implicated in autonomic regulation, however, group differences regarding HTH structural covariance were not observed. Similar observations were made in carriers and non-carriers of the ε4 allele, yet more pronounced in ε4 carriers. Although not reaching significance, comparisons of AB positive vs. negative subjects indicated stronger HTH atrophy in biomarker positive participants. HV was not associated with body mass index or longitudinal weight change.
Our findings support early structural changes of the HTH in AD. HV covaries with regional volumes of AD-vulnerable regions. This could point to secondary atrophy of the HTH following atrophy of the hippocampus and other structures of the Papez circuit in AD.
阿尔茨海默病(AD)的特征是进行性认知能力下降和特定的脑萎缩模式,主要涉及内侧颞叶。许多研究讨论了下丘脑在 AD 中的参与及其随后的代谢和/或自主功能紊乱,但只有少数研究调查了 AD 及早期阶段的下丘脑萎缩。
我们在阿尔茨海默病神经影像学倡议(ADNI)的 175 名参与者[年龄 74.9±7.22;性别 85 男/90 女;认知正常对照组(CN;N=56);遗忘型轻度认知障碍(MCI;N=78);AD(N=41)]的 3T MRI 中应用了半自动化下丘脑体积测量。此外,我们使用基于体素的形态测量学(VBM)、皮质厚度(CTH)分析和基于源的形态测量学(SBM)衍生的结构协方差网络,研究了在考虑诊断组、β-淀粉样蛋白(AB)阳性和载脂蛋白 E(APOE)ε4 状态的情况下,HTH 的脑结构协变模式。
在早期和晚期疾病阶段都观察到下丘脑萎缩(即下丘脑体积 CN>MCI>AD)。VBM、CTH 分析和 SBM 显示下丘脑体积(HV)与 AD 易损区域之间存在正相关,这些区域主要对应于 Papez 回路和与自主调节相关的大脑区域,但未观察到 HTH 结构协变的组间差异。在ε4 等位基因携带者和非携带者中也观察到了类似的观察结果,但在ε4 携带者中更为明显。尽管未达到显著水平,但与生物标志物阳性参与者相比,AB 阳性与阴性受试者的比较表明,生物标志物阳性参与者的 HTH 萎缩更为明显。HV 与体重指数或纵向体重变化无关。
我们的研究结果支持 AD 中 HTH 的早期结构变化。HV 与 AD 易损区域的区域体积相关。这可能表明 AD 中海马和 Papez 回路的其他结构萎缩后,HTH 发生了继发性萎缩。